KEGG   PATHWAY: ocu03320
Entry
ocu03320                    Pathway                                
Name
PPAR signaling pathway - Oryctolagus cuniculus (rabbit)
Description
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. PPAR has three subtypes (PPARalpha, beta/delta, and gamma) showing different expression patterns in vertebrates. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids. PPARalpha plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPARbeta/delta is involved in lipid oxidation and cell proliferation. PPARgamma promotes adipocyte differentiation to enhance blood glucose uptake.
Class
Organismal Systems; Endocrine system
Pathway map
ocu03320  PPAR signaling pathway
ocu03320

Organism
Oryctolagus cuniculus (rabbit) [GN:ocu]
Gene
100008615  PPARD; peroxisome proliferator-activated receptor delta [KO:K04504]
100008683  SCP2; sterol carrier protein 2 [KO:K08764] [EC:2.3.1.176]
100008823  DBI; acyl-CoA-binding protein [KO:K08762]
100008825  [KO:K06259]
100008882  PLTP; phospholipid transfer protein precursor [KO:K08761]
100008892  PPARG; peroxisome proliferator-activated receptor gamma [KO:K08530]
100009027  ADIPOQ; adiponectin precursor [KO:K07296]
100009110  MMP1; interstitial collagenase precursor [KO:K01388] [EC:3.4.24.7]
100009253  APOA1; apolipoprotein A-I preproprotein [KO:K08757]
100009301  CYP8B1; 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase [KO:K07431] [EC:1.14.14.139]
100009322  OLR1; oxidized low-density lipoprotein receptor 1 [KO:K08763]
100009416  [KO:K08753]
100009549  ACOX2; peroxisomal acyl-coenzyme A oxidase 2 [KO:K10214] [EC:1.17.99.3]
100144341  [KO:K01596] [EC:4.1.1.32]
100328551  CYP7A1; cytochrome P450 7A1 [KO:K00489] [EC:1.14.14.23]
100328618  UCP1; mitochondrial brown fat uncoupling protein 1 [KO:K08769]
100328719  ACSL6; long-chain-fatty-acid--CoA ligase 6 [KO:K01897] [EC:6.2.1.3]
100328796  APOA5; apolipoprotein A-V precursor [KO:K09025]
100338354  [KO:K15013] [EC:6.2.1.3]
100338450  [KO:K00232] [EC:1.3.3.6]
100338744  [KO:K01641] [EC:2.3.3.10]
100338869  [KO:K17284]
100339191  [KO:K08767]
100339653  [KO:K08758]
100340171  LPL; lipoprotein lipase precursor [KO:K01059] [EC:3.1.1.34]
100340287  [KO:K08748] [EC:6.2.1.7]
100340554  [KO:K07513] [EC:2.3.1.16]
100341327  [KO:K19524] [EC:2.3.1.21]
100342485  [KO:K01897] [EC:6.2.1.3]
100342604  [KO:K00029] [EC:1.1.1.40]
100342936  [KO:K08759]
100343479  [KO:K01641] [EC:2.3.3.10]
100344347  [KO:K01897] [EC:6.2.1.3]
100344498  [KO:K00507] [EC:1.14.19.1]
100345743  [KO:K08754]
100346046  [KO:K00507] [EC:1.14.19.1]
100346210  [KO:K08766] [EC:2.3.1.21]
100346306  [KO:K00507] [EC:1.14.19.1]
100346381  [KO:K07514] [EC:4.2.1.17 1.1.1.35 5.3.3.8]
100346561  [KO:K00507] [EC:1.14.19.1]
100347504  [KO:K00249] [EC:1.3.8.7]
100347954  [KO:K06276] [EC:2.7.11.1]
100348000  [KO:K08752]
100348736  CYP27A1; sterol 26-hydroxylase, mitochondrial precursor [KO:K00488] [EC:1.14.15.15]
100349169  [KO:K00864] [EC:2.7.1.30]
100349387  [KO:K08749]
100350311  [KO:K08765] [EC:2.3.1.21]
100350611  [KO:K08771]
100350716  [KO:K08765] [EC:2.3.1.21]
100352143  [KO:K08755]
100352217  [KO:K08745] [EC:6.2.1.-]
100352712  FADS2; acyl-CoA 6-desaturase [KO:K10226] [EC:1.14.19.3]
100352860  [KO:K08746] [EC:6.2.1.- 6.2.1.3]
100352900  NR1H3; oxysterols receptor LXR-alpha [KO:K08536]
100353138  [KO:K19523] [EC:2.3.1.21]
100353957  [KO:K06086]
100354287  [KO:K08525]
100354372  [KO:K08751]
100354503  [KO:K01897] [EC:6.2.1.3]
100354672  [KO:K08750]
100354726  [KO:K00864] [EC:2.7.1.30]
100355457  [KO:K00029] [EC:1.1.1.40]
100355759  [KO:K06272] [EC:2.7.11.1]
100356422  [KO:K07294]
100357419  [KO:K00507] [EC:1.14.19.1]
100358103  [KO:K08756]
100358351  [KO:K01897] [EC:6.2.1.3]
100358521  [KO:K00255] [EC:1.3.8.8]
100359324  [KO:K08762]
103346593  [KO:K08765] [EC:2.3.1.21]
127486972  [KO:K01897] [EC:6.2.1.3]
127488867  [KO:K08770]
127492839  [KO:K00864] [EC:2.7.1.30]
Compound
C02165  Leukotriene B4
C14762  13(S)-HODE
C14767  9(S)-HODE
C14776  8(S)-HETE
C15493  9-cis-Retinoic acid
Reference
  Authors
Takahashi N, Goto T, Kusudo T, Moriyama T, Kawada T.
  Title
[The structures and functions of peroxisome proliferator-activated receptors (PPARs)]
  Journal
Nippon Rinsho 63:557-64 (2005)
Reference
  Authors
Fujii H.
  Title
[PPARs-mediated intracellular signal transduction]
  Journal
Nippon Rinsho 63:565-71 (2005)
Reference
  Authors
Takada I, Kato S.
  Title
[PPARs target genes]
  Journal
Nippon Rinsho 63:573-7 (2005)
Reference
  Authors
Inoue H.
  Title
[Endogenous ligands for PPARs]
  Journal
Nippon Rinsho 63:578-83 (2005)
Reference
  Authors
Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W.
  Title
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
  Journal
Prog Lipid Res 45:120-59 (2006)
DOI:10.1016/j.plipres.2005.12.002
Reference
  Authors
Desvergne B, Michalik L, Wahli W.
  Title
Transcriptional regulation of metabolism.
  Journal
Physiol Rev 86:465-514 (2006)
DOI:10.1152/physrev.00025.2005
Reference
  Authors
Mandard S, Muller M, Kersten S.
  Title
Peroxisome proliferator-activated receptor alpha target genes.
  Journal
Cell Mol Life Sci 61:393-416 (2004)
DOI:10.1007/s00018-003-3216-3
Reference
  Authors
Desvergne B, Wahli W.
  Title
Peroxisome proliferator-activated receptors: nuclear control of metabolism.
  Journal
Endocr Rev 20:649-88 (1999)
DOI:10.1210/edrv.20.5.0380
Reference
  Authors
Savage DB.
  Title
PPARgamma as a metabolic regulator: insights from genomics and pharmacology.
  Journal
Expert Rev Mol Med 2005:1-16 (2005)
DOI:10.1017/S1462399405008793
Reference
  Authors
Semple RK, Chatterjee VK, O'Rahilly S.
  Title
PPAR gamma and human metabolic disease.
  Journal
J Clin Invest 116:581-9 (2006)
DOI:10.1172/JCI28003
Reference
  Authors
Lehrke M, Lazar MA.
  Title
The many faces of PPARgamma.
  Journal
Cell 123:993-9 (2005)
DOI:10.1016/j.cell.2005.11.026
Reference
  Authors
Hauner H.
  Title
The mode of action of thiazolidinediones.
  Journal
Diabetes Metab Res Rev 18 Suppl 2:S10-5 (2002)
DOI:10.1002/dmrr.249
Related
pathway
ocu00071  Fatty acid degradation
ocu00120  Primary bile acid biosynthesis
ocu00564  Glycerophospholipid metabolism
ocu04920  Adipocytokine signaling pathway
KO pathway
ko03320   

DBGET integrated database retrieval system